Dr Kent D Branson, MD | |
11630 Studt Ave, Creve Coeur, MO 63141-7016 | |
(314) 991-2229 | |
(314) 569-0339 |
Full Name | Dr Kent D Branson |
---|---|
Gender | Male |
Speciality | Obstetrics/gynecology |
Experience | 40 Years |
Location | 11630 Studt Ave, Creve Coeur, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427149038 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | R8E38 (Missouri) | Primary |
Entity Name | Kdb Enterprises Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992955926 PECOS PAC ID: 8426343765 Enrollment ID: O20160825000291 |
News Archive
Omeros Corporation today announced that the first patients have been treated in the Company's Phase 3 clinical program evaluating OMS302 in intra-ocular lens replacement surgery.
To discriminate between patients with severe and non-severe COVID-19 quickly, researchers from Peru looked for prognostic signatures in the blood samples of COVID-19 patients. Virgilio E. Failoc-Rojas et al. examined laboratory results and clinical prognosis of COVID-19 patients from a hospital in the Peruvian Amazon.
A team of researchers has brought new clarity to the picture of how gene-environmental interactions can kill nerve cells that make dopamine. Dopamine is the neurotransmitter that sends messages to the part of the brain that controls movement and coordination.
PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. announced today the execution of an agreement under which PharmaEngine grants back to Merrimack the rights to develop, manufacture, and commercialize PEP02 in Asia and Europe, with the exception of Taiwan.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kent D Branson, MD 11630 Studt Ave, Creve Coeur, MO 63141-7016 Ph: (314) 991-2229 | Dr Kent D Branson, MD 11630 Studt Ave, Creve Coeur, MO 63141-7016 Ph: (314) 991-2229 |
News Archive
Omeros Corporation today announced that the first patients have been treated in the Company's Phase 3 clinical program evaluating OMS302 in intra-ocular lens replacement surgery.
To discriminate between patients with severe and non-severe COVID-19 quickly, researchers from Peru looked for prognostic signatures in the blood samples of COVID-19 patients. Virgilio E. Failoc-Rojas et al. examined laboratory results and clinical prognosis of COVID-19 patients from a hospital in the Peruvian Amazon.
A team of researchers has brought new clarity to the picture of how gene-environmental interactions can kill nerve cells that make dopamine. Dopamine is the neurotransmitter that sends messages to the part of the brain that controls movement and coordination.
PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. announced today the execution of an agreement under which PharmaEngine grants back to Merrimack the rights to develop, manufacture, and commercialize PEP02 in Asia and Europe, with the exception of Taiwan.
› Verified 7 days ago
Dr. Patrick Peter Yeung Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 522 N New Ballas Rd Ste 300, Creve Coeur, MO 63141 Phone: 314-405-9556 Fax: 314-405-9557 |